Chris Calabrese | LifeSci Advisors, LLC |
Robert Gould | Interim Chief Executive Officer |
Esther Rajavelu | Chief Financial Officer |
Alan Ezekowitz | Board Member |
Matthew Harrison | Morgan Stanley |
Matthew Biegler | Oppenheimer |
Judah Frommer | Credit Suisse |
Dae Gon Ha | Stifel |
Edward Tenthoff | Piper Sandler |
Joseph Schwartz | SVB Securities |
Tazeen Ahmad | BofA Securities |
Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce to your host, Chris Calabrese. Thank you, Chris.
You may begin.